Questions discussed in this category
	
        	
	
	The patient has no extraocular features of a spondyloarthropathy and is on methotrexate. No active eye disease for past 1 year.
 
        	
	
	Are these toxicities expected to improve over time?
 
        	
	
	No active joint disease, patient on Hydroxychloroquine and Cimzia. Normal ESR/CRP.
 
        	
	
	Do you refer them to Ophthalmology? Have you had to switch patients off of Dupixent due to their ocular side effects?
 
 
1970420527261722221149381582716309156881567015615142551244312421110548388
 
Papers discussed in this category
	Ann Intern Med, 2020 Sep 22
Obstet Gynecol Surv,   
Arthritis Rheum,   
Int J Environ Res Public Health, 2021 Aug 01
N Engl J Med, 2021 Jun 23
BMC Rheumatol, 2021 Oct 01
Clin Ophthalmol, 2011 Oct 04
Lancet (London, England), 2025 Jan 25